|Articles|May 15, 2014
- Pharmaceutical Technology-05-15-2014
- Volume 2014 eBook
- Issue 2
Potential Benefits Drive Interest in Continuous Manufacturing
Author(s)Cynthia A. Challener
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Advertisement
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Download
.
Articles in this issue
over 11 years ago
Continuous Bioprocessing Challengesover 11 years ago
Optimizing the Sterilization of Liquids in Sealed Containersover 11 years ago
Using Modular Systems in Biopharmaceutical Manufacturingover 11 years ago
Determining Protein Oxidation Induced During Fill-Finish Operationsover 11 years ago
Single-Use Technology in Parenteral Fill/FinishNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
3
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
4
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
5
